96982 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones Corticotropin releasing factor [CRF] (Urotensin)
CRF2 RECEPTOR AGONISTS AND THEIR USE IN THERAPY
#2COMPOUNDS FOR THE TREATMENT OF DIABETES OR OBESITY
#3ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#4AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#5Dietary peptides
#6Antigenic peptides deriving from urocortin 3 and uses thereof for the diagnosis and treatment of type 1 diabetes
#7METHODS AND COMPOSITIONS FOR TREATING HPA HYPERACTIVITY
#8Method of treating type I diabetes using an AAV vector encoding uracortin 2
#9Amino diacids containing peptide modifiers
#10Method for preventing or treating heart failure by administering a medicament containing an antagonist of corticotropin releasing hormone receptor 2 (CRHR2)
#11Dietary peptides
#12UROCORTIN 2 ANALOGS AND USES THEREOF
#13Fatty acid modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease
#14Method of treating type I diabetes using an AAV vector encoding uracortin 2
#15SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC DYSFUNCTIONS AND CONGESTIVE HEART FAILURE
#16AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#17SYSTEMIC DELIVERY OF VIRUS VECTORS ENCODING UROCORTIN-2 AND RELATED GENES TO TREAT DIABETES-RELATED CARDIAC DYSFUNCTIONS AND CONGESTIVE HEART FAILURE
#18Methods for the expression of peptides and proteins
#19Urocortin 2 analogs and uses thereof
#20Stresscopins and their Uses
#21Urocortin-III and uses thereof
#22Agonists and antagonists of the urotensinergic system
#23Cyclic CRF antagonist peptides
#24Urocortin-III and uses thereof
#25UROCORTIN 2 ANALOGS AND USES THEREOF
#26Antibodies that bind stresscopin peptides
#27CRH and POMC effects on animal growth
#28CRF1 RECEPTOR COMPOUNDS
#29USE OF CARDIAC HORMONES TO ASSESS RISK OF CARDIOVASCULAR COMPLICATION FROM VOLUME OVERLOAD
#30Chimera Compositions and Methods of Use
#31CRF CONJUGATES WITH EXTENDED HALF-LIVES
#32Corticotropin releasing factor 2 receptor agonists
#33Urocortin proteins and uses thereof
#34CRHR2 peptide agonists and uses thereof
#35CRH and POMC effects on animal growth
#36Urocortin-III and uses thereof
#37CRFR1 selective ligands
#38Corticotropin releasing factor 2 receptor agonists
#39ACTIVATABLE CLOSTRIDIAL TOXINS
#40High purity peptides
#41Novel Corticotropin-Releasing Factor Receptor 1 (Crfr1) Agonist
#42Modified corticotropin releasing factor peptides and uses thereof
#43Stresscopins and their uses
#44CHR and POMC effects on animal growth
#45Corticotropin releasing factor 2 receptor agonists
#46Urotensin-II agonists and antagonists
#47Urocortin proteins and uses thereof
#48Promoter sequences for urocortin II and the use thereof
#49Corticotropin releasing factor 2 receptor agonists
#50Urocortin-III and uses thereof
#51Use of cardiac hormones to assess risk of cardiovascular complication from volume overload
#52CRH and POMC effects on animal growth
#53Urocortin proteins and uses thereof
#54Corticotropin-releasing hormone analogs and their uses
#55Urotensin-II agonists and antagonists